OPCH Stock Analysis: Buy, Sell, or Hold?
OPCH - Option Care Health, Inc. Common Stock
$27.00
-0.27 (-0.99%)
▼
5d:
-4.96%
30d:
-16.82%
90d:
-17.13%
BUY
HIGH Confidence
Analysis Updated: Mar 30, 2026 12:00 AM ET
Earnings: May 05, 2026
Get Alerted When OPCH Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: OPCH trading at deep discount. Market pricing in -8.8% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: OPCH trading at deep discount. Market pricing in -8.8% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$54.61
Based on 9.0% avg growth
INTRINSIC VALUE TODAY
$33.91
20.4% Margin of Safety
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 16.7x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: OPCH is currently trading at $27.00, which is considered oversold relative to its 30-day fair value range of $28.88 to $34.08. From a valuation perspective, the stock is trading at a discount (Forward PE: 12.7) compared to its historical average (16.7). Remarkably, the market is currently pricing in an annual earnings decline of 8.8% over the next few years. This pessimistic expectation contrasts with the company's recent 1.3% earnings growth, suggesting potential undervaluation if the company simply maintains stability.
Technical Outlook: Technically, OPCH is showing sideways momentum. The price is currently testing key support at $27.07. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $40.09 (+48.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, OPCH is showing sideways momentum. The price is currently testing key support at $27.07. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $40.09 (+48.5%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
OVERSOLD
Fair Price Range
$28.88 -
$34.08
Company Quality Score
54/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
79.5%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 48.5% below Wall St target ($40.09)
Fair Price Analysis
30-Day Fair Range
$28.88 -
$34.08
Current vs Fair Value
OVERSOLD
Support & Resistance Levels
Support Level
$27.08
Resistance Level
$30.32
Current Trend
Sideways
Technical data as of
Mar 30, 2026
Fundamental Context
Forward P/E (Next Year Est.)
12.70
Wall Street Target
$40.09
(+48.5%)
Revenue Growth (YoY)
8.8%
Earnings Growth (YoY)
1.3%
Profit Margin
3.7%
Valuation Discount vs History
-8.8% cheaper
PE vs Historical
12.7 vs 16.7
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-8.8%
(market-implied from PE analysis)
1-Year Target
$24.62
(-9%)
2-Year Target
$22.46
(-17%)
3-Year Target
$20.48
(-24%)
3-Yr Target (if PE normalizes)
(PE: 13→17)
$26.93
(0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 22.4, Growth: 14.1%)
$70.56
(+161%)
Base:
(SPY PE: 12.7, Growth: 14.1%)
$40.09
(+49%)
Bear:
(PE: 10.8, Growth: 14.1%)
$34.08
(+26%)
📈
Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (22x PE), but valuation improves significantly next year (13x PE) as earnings recover.
Trailing PE: 22.17 | Current EPS (TTM): $1.27
Bull Case
$51.90
(+83%)
Analyst growth 67.6%, PE expands to 24.4
Base Case
$47.18
(+66%)
Market implied 67.6%, PE stable at 22.2
Bear Case
$19.15
(-33%)
Severe decline -20.0%, PE contracts to 18.9
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 12.7 to 16.7
Stabilization Target:
$35.50
(+31.5%)
PE Expansion Potential:
+31.5%
Share & Embed Analysis
Last updated: March 31, 2026 12:09 AM ET
Data refreshes hourly during market hours. Next update: 1:09 AM
Data refreshes hourly during market hours. Next update: 1:09 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OPCH showing a specific setup today?
Insider Activity (6 Months)
2
Buys
2
Sells
0
Net
NEUTRAL
Recent Transactions
Harry M Jansen Kraemer Jr
BUY
38000 shares
2025-11-03
Lisa C. McClain
SELL
2025-10-31
Lisa C. McClain
SELL
2025-10-30
Top Rated Medical Care Facilities Stocks
Top-rated stocks in Medical Care Facilities by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
THC
Tenet Healthcare Corpora… |
STRONG BUY
22 analysts |
$261 | 62 BUY |
|
HCA
HCA Holdings Inc |
BUY
25 analysts |
$543 | 64 BUY |
|
EHC
Encompass Health Corp |
STRONG BUY
12 analysts |
$143 | 56 HOLD |
|
CMPS
Compass Pathways Plc |
STRONG BUY
11 analysts |
$22 | 48 HOLD |
|
ADUS
Addus HomeCare Corporati… |
STRONG BUY
11 analysts |
$140 | 54 HOLD |
